cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.15156/bio/sh1399698.10fu
title: SH1399698.10FU

description: UNITE provides a unified way for delimiting, identifying, communicating, and working with DNA-based Species Hypotheses (SH). All fungal ITS sequences in the international nucleotide sequence databases are clustered to approximately the species level by applying a set of dynamic distance values (<0.5 - 3.0%). All species hypotheses are given a unique, stable name in the form of a DOI, and their taxonomic and ecological annotations are verified through distributed, web-based third-party annotation efforts. SHs are connected to a taxon name and its classification as far as possible (phylum, class, order, etc.) by taking into account identifications for all sequences in the SH. An automatically or manually designated sequence is chosen to represent each such SH. These sequences are released (https://unite.ut.ee/repository.php) for use by the scientific community in, for example, local sequence similarity searches and next-generation sequencing analysis pipelines. The system and the data are updated automatically as the number of public fungal ITS sequences grows.
DOI: 10.15156/bio/sh1399701.10fu
title: SH1399701.10FU

description: UNITE provides a unified way for delimiting, identifying, communicating, and working with DNA-based Species Hypotheses (SH). All fungal ITS sequences in the international nucleotide sequence databases are clustered to approximately the species level by applying a set of dynamic distance values (<0.5 - 3.0%). All species hypotheses are given a unique, stable name in the form of a DOI, and their taxonomic and ecological annotations are verified through distributed, web-based third-party annotation efforts. SHs are connected to a taxon name and its classification as far as possible (phylum, class, order, etc.) by taking into account identifications for all sequences in the SH. An automatically or manually designated sequence is chosen to represent each such SH. These sequences are released (https://unite.ut.ee/repository.php) for use by the scientific community in, for example, local sequence similarity searches and next-generation sequencing analysis pipelines. The system and the data are updated automatically as the number of public fungal ITS sequences grows.
DOI: 10.15156/bio/sh1399709.10fu
title: SH1399709.10FU

description: UNITE provides a unified way for delimiting, identifying, communicating, and working with DNA-based Species Hypotheses (SH). All fungal ITS sequences in the international nucleotide sequence databases are clustered to approximately the species level by applying a set of dynamic distance values (<0.5 - 3.0%). All species hypotheses are given a unique, stable name in the form of a DOI, and their taxonomic and ecological annotations are verified through distributed, web-based third-party annotation efforts. SHs are connected to a taxon name and its classification as far as possible (phylum, class, order, etc.) by taking into account identifications for all sequences in the SH. An automatically or manually designated sequence is chosen to represent each such SH. These sequences are released (https://unite.ut.ee/repository.php) for use by the scientific community in, for example, local sequence similarity searches and next-generation sequencing analysis pipelines. The system and the data are updated automatically as the number of public fungal ITS sequences grows.
DOI: 10.15156/bio/sh1399714.10fu
title: SH1399714.10FU

description: UNITE provides a unified way for delimiting, identifying, communicating, and working with DNA-based Species Hypotheses (SH). All fungal ITS sequences in the international nucleotide sequence databases are clustered to approximately the species level by applying a set of dynamic distance values (<0.5 - 3.0%). All species hypotheses are given a unique, stable name in the form of a DOI, and their taxonomic and ecological annotations are verified through distributed, web-based third-party annotation efforts. SHs are connected to a taxon name and its classification as far as possible (phylum, class, order, etc.) by taking into account identifications for all sequences in the SH. An automatically or manually designated sequence is chosen to represent each such SH. These sequences are released (https://unite.ut.ee/repository.php) for use by the scientific community in, for example, local sequence similarity searches and next-generation sequencing analysis pipelines. The system and the data are updated automatically as the number of public fungal ITS sequences grows.
DOI: 10.6084/m9.figshare.29598398
title: Supplementary Material for: Development of the European Association for the Study of Obesity (EASO) Grade-Based Framework on the Pharmacological Treatment of Obesity: Design and Methodological Aspects.

description: Aim: To describe the design and methodological aspects of the upcoming European Association for the Study of Obesity (EASO) Framework for the Pharmacological Treatment of Obesity utilizing currently available evidence.
Methods: An expert panel of 13 members, selected by EASO, developed the framework using the GRADE methodology to ensure transparent, evidence-based guideline development. Clinical questions were formulated using the Population, Intervention, Comparator, Outcomes (PICO) framework, focusing on the effectiveness and safety of European Medicines Agency-approved obesity management medications (OMM), including orlistat, naltrexone/bupropion, liraglutide, semaglutide, and tirzepatide. A comprehensive literature search will be conducted using Medline and Embase, including randomized controlled trials with a minimum duration of 48 weeks. Meta-analyses and network meta-analyses will be conducted to compare treatment effectiveness and safety profiles across various patient subgroups.
Results: The guidelines will target adults with a body mass index (BMI) ≥27 kg/m² and at least one weight-related comorbidity or a BMI ≥30 kg/m². The primary endpoint will be total body weight loss (TBWL%). Secondary outcomes will be changes in body composition (i.e., fat mass, fat-free mass), metabolic improvements (i.e., glucose levels, HbA1c, lipid profile), remission of obesity-related comorbidities (i.e., type 2 diabetes, obstructive sleep apnoea syndrome, metabolic dysfunction-associated steatotic liver disease, cardiovascular disease, and knee osteoarthritis), and improvements in mental health and quality of life. Preliminary analyses suggest that this framework will provide structured, individualized treatment recommendations based on the latest evidence.
Conclusions: The EASO framework aims to optimize pharmacological treatment for obesity through an individualized, evidence-based approach. By integrating clinical efficacy, safety outcomes, and patient-specific factors, these guidelines will support healthcare professionals in improving obesity management and its related comorbidities.
DOI: 10.6084/m9.figshare.29598398.v1
title: Supplementary Material for: Development of the European Association for the Study of Obesity (EASO) Grade-Based Framework on the Pharmacological Treatment of Obesity: Design and Methodological Aspects.

description: Aim: To describe the design and methodological aspects of the upcoming European Association for the Study of Obesity (EASO) Framework for the Pharmacological Treatment of Obesity utilizing currently available evidence.
Methods: An expert panel of 13 members, selected by EASO, developed the framework using the GRADE methodology to ensure transparent, evidence-based guideline development. Clinical questions were formulated using the Population, Intervention, Comparator, Outcomes (PICO) framework, focusing on the effectiveness and safety of European Medicines Agency-approved obesity management medications (OMM), including orlistat, naltrexone/bupropion, liraglutide, semaglutide, and tirzepatide. A comprehensive literature search will be conducted using Medline and Embase, including randomized controlled trials with a minimum duration of 48 weeks. Meta-analyses and network meta-analyses will be conducted to compare treatment effectiveness and safety profiles across various patient subgroups.
Results: The guidelines will target adults with a body mass index (BMI) ≥27 kg/m² and at least one weight-related comorbidity or a BMI ≥30 kg/m². The primary endpoint will be total body weight loss (TBWL%). Secondary outcomes will be changes in body composition (i.e., fat mass, fat-free mass), metabolic improvements (i.e., glucose levels, HbA1c, lipid profile), remission of obesity-related comorbidities (i.e., type 2 diabetes, obstructive sleep apnoea syndrome, metabolic dysfunction-associated steatotic liver disease, cardiovascular disease, and knee osteoarthritis), and improvements in mental health and quality of life. Preliminary analyses suggest that this framework will provide structured, individualized treatment recommendations based on the latest evidence.
Conclusions: The EASO framework aims to optimize pharmacological treatment for obesity through an individualized, evidence-based approach. By integrating clinical efficacy, safety outcomes, and patient-specific factors, these guidelines will support healthcare professionals in improving obesity management and its related comorbidities.
DOI: 10.6084/m9.figshare.29598401
title: Supplementary Material for: Causal associations of gestational and perinatal factors with the risk of childhood obesity: A Mendelian Randomization study

description: Introduction: This study was to explore the causal association between gestational and perinatal factors and the risk of childhood obesity based on two-sample Mendelian Randomization (MR).
Methods: The single-nucleotide polymorphisms (SNPs) associated with exposure were selected. MR Egger regression was used for the evaluation of the horizontal pleiotropy in SNPs. F-statistic reflects the strength of instrumental variables. Cochran’s Q statistic was used to investigate the heterogeneity of SNPs. The primary MR method exploring the causal association between gestational and perinatal factors and the risk of childhood obesity was inverse variance weighted (IVW). Leave-one-out analysis was employed to identify whether the MR results were affected by single SNPs. Odds ratio (OR) and 95% confidence interval (CI) were imputed.
Results: IVW indicated that birth weight was a risk factor for childhood body mass index (BMI) (OR=1.347, 95%CI: 1.212-1.498) and childhood obesity (OR=1.793, 95%CI: 1.300-2.473). Increased risk of childhood obesity was identified in mother with gestational diabetes (OR=1.059, 95%CI: 1.006-1.116). Gestational diabetes was causally related to elevated childhood BMI. Gestational diabetes was causally related to elevated risk of childhood obesity (OR=1.249, 95%CI: 1.044-1.495).
Conclusions: Birth weight and gestational diabetes was causally related to childhood BMI and childhood obesity.
DOI: 10.6084/m9.figshare.29598401.v1
title: Supplementary Material for: Causal associations of gestational and perinatal factors with the risk of childhood obesity: A Mendelian Randomization study

description: Introduction: This study was to explore the causal association between gestational and perinatal factors and the risk of childhood obesity based on two-sample Mendelian Randomization (MR).
Methods: The single-nucleotide polymorphisms (SNPs) associated with exposure were selected. MR Egger regression was used for the evaluation of the horizontal pleiotropy in SNPs. F-statistic reflects the strength of instrumental variables. Cochran’s Q statistic was used to investigate the heterogeneity of SNPs. The primary MR method exploring the causal association between gestational and perinatal factors and the risk of childhood obesity was inverse variance weighted (IVW). Leave-one-out analysis was employed to identify whether the MR results were affected by single SNPs. Odds ratio (OR) and 95% confidence interval (CI) were imputed.
Results: IVW indicated that birth weight was a risk factor for childhood body mass index (BMI) (OR=1.347, 95%CI: 1.212-1.498) and childhood obesity (OR=1.793, 95%CI: 1.300-2.473). Increased risk of childhood obesity was identified in mother with gestational diabetes (OR=1.059, 95%CI: 1.006-1.116). Gestational diabetes was causally related to elevated childhood BMI. Gestational diabetes was causally related to elevated risk of childhood obesity (OR=1.249, 95%CI: 1.044-1.495).
Conclusions: Birth weight and gestational diabetes was causally related to childhood BMI and childhood obesity.
DOI: 10.34740/kaggle/dsv/12508755
title: Peer-to-Peer Boliviano (BOB) Exchange Data
DOI: 10.6084/m9.figshare.29598404
title: Supplementary Material for: Tinnitus and Sensory Dysfunctions: A Cohort Study from Health Checkups Before and during COVID-19 Endemic

description: Introduction: Tinnitus and smell dysfunction have been reported to be associated. The long-term course of tinnitus and sensory dysfunctions, including smell and taste dysfunctions, after COVID-19 infection needs to be studied further. 
Materials and Methods: A cohort study of tinnitus and sensory dysfunctions before and during the COVID-19 pandemic was conducted through health checkups in a rural area in Japan. Five hundred ten participants attended health checkups in August 2019, 434 in 2023, and 437 in 2024. Two hundred twenty-five participants attended the 2019 and 2023 health checkups, and one hundred seventy-one participants attended all three. The subjects included people 40 years of age or older. The questionnaire included information on tinnitus, hearing, vertigo, headache, smell, taste, and lifestyle habits. In 2023, the questionnaire included questions about COVID-19. 
Results: Tinnitus, hearing impairment, and smell dysfunction were associated. Fear and anxiety about COVID-19 infection were significantly associated with tinnitus after adjusting for age and sex. Irregular sleep time and fewer sports and exercise habits were significantly associated with tinnitus, but not smell or taste dysfunction. In an investigation of identical persons, deterioration of tinnitus was conspicuous in 2023 compared to 2019 in persons with strong fear and anxiety about COVID-19. 
Conclusions: Tinnitus is related to lifestyle habits compared to other sensory disorders. Fear and anxiety about COVID-19, rather than COVID-19 infection itself, significantly influenced tinnitus during the COVID-19 pandemic in rural areas.
DOI: 10.6084/m9.figshare.29598404.v1
title: Supplementary Material for: Tinnitus and Sensory Dysfunctions: A Cohort Study from Health Checkups Before and during COVID-19 Endemic

description: Introduction: Tinnitus and smell dysfunction have been reported to be associated. The long-term course of tinnitus and sensory dysfunctions, including smell and taste dysfunctions, after COVID-19 infection needs to be studied further. 
Materials and Methods: A cohort study of tinnitus and sensory dysfunctions before and during the COVID-19 pandemic was conducted through health checkups in a rural area in Japan. Five hundred ten participants attended health checkups in August 2019, 434 in 2023, and 437 in 2024. Two hundred twenty-five participants attended the 2019 and 2023 health checkups, and one hundred seventy-one participants attended all three. The subjects included people 40 years of age or older. The questionnaire included information on tinnitus, hearing, vertigo, headache, smell, taste, and lifestyle habits. In 2023, the questionnaire included questions about COVID-19. 
Results: Tinnitus, hearing impairment, and smell dysfunction were associated. Fear and anxiety about COVID-19 infection were significantly associated with tinnitus after adjusting for age and sex. Irregular sleep time and fewer sports and exercise habits were significantly associated with tinnitus, but not smell or taste dysfunction. In an investigation of identical persons, deterioration of tinnitus was conspicuous in 2023 compared to 2019 in persons with strong fear and anxiety about COVID-19. 
Conclusions: Tinnitus is related to lifestyle habits compared to other sensory disorders. Fear and anxiety about COVID-19, rather than COVID-19 infection itself, significantly influenced tinnitus during the COVID-19 pandemic in rural areas.
DOI: 10.15468/dl.4wycm9
title: Occurrence Download

description: A dataset containing 0 species occurrences available in GBIF matching the query:
{
 "and" : [
 "HasGeospatialIssue is false",
 "HasCoordinate is true",
 "OccurrenceStatus is Present",
 "BasisOfRecord is one of (Human Observation, Machine Observation, Occurrence evidence, Observation)",
 "TaxonKey is one of (Glaucidium gnoma)",
 "Country is one of (American Samoa, Australia, Christmas Island, Cocos (Keeling) Islands, Cook Islands, Fiji, French Polynesia, Guam, Heard Island and McDonald Islands, Kiribati, Marshall Islands, Micronesia (Federated States of), Nauru, New Caledonia, New Zealand, Niue, Norfolk Island, Northern Mariana Islands, Palau, Papua New Guinea, Pitcairn, Samoa, Solomon Islands, Tokelau, Tonga, Tuvalu, United States Minor Outlying Islands, Vanuatu, Wallis and Futuna)"
 ]
}

 The dataset includes 0 records from 0 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0007122-250717081556266/datasets/export for details.
DOI: 10.6084/m9.figshare.29598407
title: Supplementary Material for: Air Cholangiography Vs Contrast Cholangiography in Patients with Hilar Biliary Obstruction: A Systematic Review and Meta-analysis

description: Background/Aims:
To minimize the risk of post-procedure complications, air cholangiography has been proposed as an alternative to contrast cholangiography in patients with hilar biliary obstruction undergoing endoscopic retrograde cholangiography. We compared the rate of post-ERCP complication between these two groups.
Methods:
We systematically reviewed all studies that compared the safety, success, and complication rate of air vs contrast cholangiography in malignant hilar obstruction patients. 
Results:
A total of six studies consisting of 450 patients were included in the analysis. The overall rate of post-ERCP complication was less in the air cholangiography group (RR 0.43, 95% CI 0.30-0.61, I2 1.97%)) compared to the contrast cholangiography group. Compared to contrast cholangiography, the pooled risk of post-ERCP cholangitis was significantly lower in the air cholangiography group (RR 0.25, 95% CI 0.14-0.44, I2 0%). There was no difference in risk of post-ERCP pancreatitis (RR 0.79, 95% CI 0.32-1.94, I2 0%), bleeding (RR 1.17, 95% CI 0.30-4.54) and 30-day mortality (RR 0.59, 95% CI 0.23-1.50, I2 0%) between the two groups. The pooled odds of clinical (OR 1.14, 95% CI 0.39-3.34, I2 0%) and technical success (OR 2.91, 95% CI 0.52-16.35, I2 0%) were similar between both groups.
Conclusion:
In comparison to contrast cholangiography, air cholangiography had a better safety profile and less rate of post-ERCP complications. 


Keywords:
Endoscopic retrograde cholangiopancreatography, Air cholangiogram, Contrast cholangiogram, Cholangitis, meta-analysis.
DOI: 10.6084/m9.figshare.29598407.v1
title: Supplementary Material for: Air Cholangiography Vs Contrast Cholangiography in Patients with Hilar Biliary Obstruction: A Systematic Review and Meta-analysis

description: Background/Aims:
To minimize the risk of post-procedure complications, air cholangiography has been proposed as an alternative to contrast cholangiography in patients with hilar biliary obstruction undergoing endoscopic retrograde cholangiography. We compared the rate of post-ERCP complication between these two groups.
Methods:
We systematically reviewed all studies that compared the safety, success, and complication rate of air vs contrast cholangiography in malignant hilar obstruction patients. 
Results:
A total of six studies consisting of 450 patients were included in the analysis. The overall rate of post-ERCP complication was less in the air cholangiography group (RR 0.43, 95% CI 0.30-0.61, I2 1.97%)) compared to the contrast cholangiography group. Compared to contrast cholangiography, the pooled risk of post-ERCP cholangitis was significantly lower in the air cholangiography group (RR 0.25, 95% CI 0.14-0.44, I2 0%). There was no difference in risk of post-ERCP pancreatitis (RR 0.79, 95% CI 0.32-1.94, I2 0%), bleeding (RR 1.17, 95% CI 0.30-4.54) and 30-day mortality (RR 0.59, 95% CI 0.23-1.50, I2 0%) between the two groups. The pooled odds of clinical (OR 1.14, 95% CI 0.39-3.34, I2 0%) and technical success (OR 2.91, 95% CI 0.52-16.35, I2 0%) were similar between both groups.
Conclusion:
In comparison to contrast cholangiography, air cholangiography had a better safety profile and less rate of post-ERCP complications. 


Keywords:
Endoscopic retrograde cholangiopancreatography, Air cholangiogram, Contrast cholangiogram, Cholangitis, meta-analysis.
DOI: 10.15468/dl.nt8p32
title: Occurrence Download

description: A dataset containing 0 species occurrences available in GBIF matching the query:
{
 "and" : [
 "HasGeospatialIssue is false",
 "HasCoordinate is true",
 "OccurrenceStatus is Present",
 "BasisOfRecord is one of (Human Observation, Machine Observation, Occurrence evidence, Observation)",
 "TaxonKey is one of (Glaucidium gnoma)",
 "Country is one of (Algeria, Angola, Benin, Botswana, British Indian Ocean Territory, Burkina Faso, Burundi, Cabo Verde, Cameroon, Central African Republic, Chad, Comoros, Congo, Congo, Democratic Republic of the, Côte d’Ivoire, Djibouti, Egypt, Equatorial Guinea, Eritrea, Eswatini, Ethiopia, French Southern Territories, Gabon, Gambia, Ghana, Guinea, Guinea-Bissau, Kenya, Lesotho, Liberia, Libya, Madagascar, Malawi, Mali, Mauritania, Mauritius, Mayotte, Morocco, Mozambique, Namibia, Niger, Nigeria, Réunion, Rwanda, Saint Helena, Ascension and Tristan da Cunha, Sao Tome and Principe, Senegal, Seychelles, Sierra Leone, Somalia, South Africa, South Sudan, Sudan, Tanzania, United Republic of, Togo, Tunisia, Uganda, Western Sahara, Zambia, Zimbabwe)"
 ]
}

 The dataset includes 0 records from 0 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0007123-250717081556266/datasets/export for details.
DOI: 10.25574/28128
title: Chandra X-ray Observatory ObsId 28128

description: G359.55+0.16: a case of interstellar magnetic reconnection?
DOI: 10.15468/dl.b9n8du
title: Occurrence Download

description: A dataset containing 196644 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is one of (Heracleum mantegazzianum, Heracleum mantegazzianum immaculatum, Heracleum mantegazzianum rosicalyx, Heracleum grossheimii, Heracleum circassicum, Heracleum speciosum, Heracleum montegazzianum, Pastinaca mantegazziana)",
 "HasCoordinate is true",
 "HasGeospatialIssue is false",
 "Year is greater than or equal to 2000"
 ]
}

 The dataset includes 196644 records from 442 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0007093-250717081556266/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.usyy5h
title: Occurrence Download

description: A dataset containing 1489 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Country is Colombia",
 "Elevation 0.0-800.0m",
 "Geometry POLYGON((-76.72592 7.99933,-76.12993 7.99933,-76.12993 8.20899,-76.72592 8.20899,-76.72592 7.99933))",
 "HasGeospatialIssue is false",
 "OccurrenceStatus is Present",
 "TaxonKey is one of (Amphibia, Reptilia, Reptilia, Squamata, Testudines, Crocodylia, Mammalia, Aves)"
 ]
}

 The dataset includes 1489 records from 10 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0007124-250717081556266/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.